BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 889645)

  • 1. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dantrolene in porcine malignant hyperthermia.
    Gronert GA; Milde JH; Theye RA
    Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
    Harrison GG
    Br J Anaesth; 1975 Jan; 47(1):62-5. PubMed ID: 1148076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
    Flewellen EH; Nelson TE
    Anesthesiology; 1980 Apr; 52(4):303-8. PubMed ID: 7362049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
    Gallant EM; Foldes FF; Rempel WE; Gronert GA
    Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of ryanodine toxicity by dantrolene and halothane in a model of malignant hyperthermia.
    Fairhurst AS; Hamamoto V; Macri J
    Anesthesiology; 1980 Sep; 53(3):199-204. PubMed ID: 7425333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
    Patil PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
    Alitalo I; Schulman A
    Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia susceptibility--successful management with a "stressfree" technique.
    Jantzen JP; Erdmann K; Kleemann PP
    Acta Anaesthesiol Belg; 1987; 38(1):107-13. PubMed ID: 3591264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
    Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
    Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.
    Nelson TE; Flewellen EH
    Anesthesiology; 1979 Feb; 50(2):118-22. PubMed ID: 434484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
    Anderson IL; Jones EW
    Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia.
    Halliday NJ
    J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo induced malignant hyperthermia in pigs. I. Physiological and biochemical changes and the influence of dantrolene sodium.
    Verburg MP; Oerlemans FT; van Bennekom CA; Gielen MJ; de Bruyn CH; Crul JF
    Acta Anaesthesiol Scand; 1984 Feb; 28(1):1-8. PubMed ID: 6711253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).
    Flewellen EH; Nelson TE; Bee DE
    Can Anaesth Soc J; 1980 Jan; 27(1):16-21. PubMed ID: 7353186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of porcine malignant hyperpyrexia. The successful use of dantrolene in the Pietrain pig.
    Hall GM; Lucke JN; Lister D
    Anaesthesia; 1977 May; 32(5):472-4. PubMed ID: 869147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia: a potentially fatal complication of anesthesia.
    Stolworthy C; Haas RE
    Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
    Free CW; Jaimon MP
    N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
    Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
    J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.